BJU International

Papers
(The H4-Index of BJU International is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Reply to ‘Comment on Bertini et al.: area deprivation and PSA screening disparities’ and ‘Comment on socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivati119
Response to Chen et al.96
The European Association of Urology talent incubator: bridging competencies for holistic urological care79
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer79
64
April's reviewers of the month63
Efficacy of RestoreX after prostatectomy: open‐label phase of a randomised controlled trial62
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension57
Recent key papers in prostate cancer54
Editorial Board51
The LANDMARK project: providing summaries of key papers that have shaped urological practice51
Flexible ureterorenoscopy or extracorporeal shockwave lithotripsy in stone disease and bevacizumab for hereditary and sporadic papillary renal‐cell cancer46
46
Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?46
Author Index44
September's reviewers of the month43
MRI , Prostate cancer diagnosis, and Artificial Intelligence; What are the implications?42
Eve's and Adam's rib for prostate cancer screening42
Age‐related PSA testing for prostate cancer: NICE recommendation 1.6.339
Editorial Board38
The impact of post‐nephroureterectomy surgically induced chronic kidney disease on survival outcomes37
MRI in combination with Technetium‐99m‐sestamibi single‐photon emission CT/CT: a novel diagnostic algorithm to maximise the characterisation of small renal masses35
Impact of the COVID‐19 pandemic on the burnout rates of graduating Canadian Urology residents34
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?33
Surveillance of non‐muscle ‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis32
Frail and forgotten: an EAU YAU call for trainee‐led research on frailty in urology31
ChatGPT – Integrity: Artificial Intelligence Misuse in Medical Writing31
Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial30
Prolonged ischaemia during partial nephrectomy: impact of warm vs cold29
Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?29
1.0835599899292